marijuana stock news

mCig, Inc. (MCIG)

 

Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
Period Ending Jul 31, 2015 Apr 30, 2015 Jan 31, 2015 Oct 31, 2014
Total Revenue 369   66   88   249  
Cost of Revenue 242 208 28 117
Gross Profit 127   (142) 61   132  
Operating Expenses
Research Development 37
Selling General and Administrative 788 1,507 803 901
Non Recurring
Others 2 1 2 2
Total Operating Expenses
Operating Income or Loss (663) (1,687) (744) (771)
Income from Continuing Operations
Total Other Income/Expenses Net (639)
Earnings Before Interest And Taxes (663) (2,326) (744) (771)
Interest Expense
Income Before Tax (663) (2,326) (744) (771)
Income Tax Expense
Minority Interest
Net Income From Continuing Ops (663) (2,326) (744) (771)
Non-recurring Events
Discontinued Operations 36 (8)
Extraordinary Items
Effect Of Accounting Changes
Other Items
Net Income (663) (2,290) (744) (779)
Preferred Stock And Other Adjustments
Net Income Applicable To Common Shares (663) (2,290) (744) (779)

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Green Thumb Industries Inc. (GTBIF) to Hold First Quarter 2023 Earnings Conference Call on May 3, 2023

Green Thumb Industries to Hold First Quarter 2023 Earnings Conference Call on…

Cresco Labs (CRLBF) Sunnyside Dispensary Expands to Tallahassee

Cresco Labs’ Sunnyside Dispensary Expands to Tallahassee Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco…

AbbVie Inc. (ABBV) to Present at the Morgan Stanley Healthcare Conference

AbbVie to Present at the Morgan Stanley Healthcare Conference AbbVie (NYSE: ABBV)…

GW Pharmaceuticals plc (GWPH) presents latest cannabidiol oral solution (CBD) data

GW Pharmaceuticals presents latest cannabidiol oral solution (CBD) data at the 13th…